
Enlace Bio provides AI-driven binding predictions to accelerate hit discovery in early drug discovery. It uses AI models that learn biochemical interaction patterns to rank compounds by predicted affinity and selectivity. The core technology includes AI-based virtual screening and AI cofolding to simulate 3D protein-ligand complexes from amino acid sequences. The service targets medicinal chemistry teams working on novel protein targets, offering virtual screening results and compound prioritization. This approach reduces experimental screening load and scales across large chemical libraries.

Enlace Bio provides AI-driven binding predictions to accelerate hit discovery in early drug discovery. It uses AI models that learn biochemical interaction patterns to rank compounds by predicted affinity and selectivity. The core technology includes AI-based virtual screening and AI cofolding to simulate 3D protein-ligand complexes from amino acid sequences. The service targets medicinal chemistry teams working on novel protein targets, offering virtual screening results and compound prioritization. This approach reduces experimental screening load and scales across large chemical libraries.